Intellectual Property News & Topics - Secerna LLP

XTANDI

A to Z: Drugs in Highlight: X is for XTANDI®

News A to Z Feature 15/05/2025

Our A to Z series highlights XTANDI® (from Pfizer and Astellas Pharma) is used to treat men with prostate cancer. Learn more about XTANDI®'s mechanism of action, market impact, and patent protection.

Read more

KALYDECO

News, A to Z Feature 13/02/2025

A to Z: Drugs in Highlight: K is for KALYDECO®

News 11/02/2025

Protect Your Global Brand: Essential Trade Mark Services

J Is For JANUVIA® (1)

News, A to Z Feature 06/02/2025

A to Z: Drugs in Highlight: J is for JANUVIA®

EU FLAG Canva

Industry news, News 03/02/2025

UPC finds infringement by way of equivalence for the first time

IMBRUVICA

News, A to Z Feature 30/01/2025

A to Z: Drugs in Highlight: I is for IMBRUVICA®

Secerna Website Images 2025 (4)

Industry news, News 27/01/2025

Unlocking Faster Cancer Treatments: The Power of Project Orbis

Secerna Website Images 2025 (3)

Industry news, News, Team news 24/01/2025

Secerna Expands Life Sciences Team with the Addition of Trainee Patent Attorney

HERCEPTIN

News, A to Z Feature 23/01/2025

A to Z: Drugs in Highlight: H is for HERCEPTIN®

EPO 2021

European, News 21/01/2025

Added Matter Objections at the European Patent Office (EPO)

1 2 3 4 5 6 7 8 9 10